Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Axitinib

Review the clinical trials studying axitinib on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-10 of 10

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy with or without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Status: Active
Location: 441 locations
Testing the Addition of Stereotactic Radiation Therapy with Immune Therapy for the Treatment of Patients with Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Status: Active
Location: 264 locations
Neoadjuvant Pembrolizumab and Axitinib for Treatment of Patients with Kidney Cell Carcinoma and Associated Inferior Vena Cava Tumor Thrombus, NEOPAX Trial
Status: Active
Location: 3 locations
Nivolumab in Combination with Axitinib for the Treatment of Advanced or Unresectable Mucosal Melanoma
Status: Active
Location: 2 locations
Implantable Microdevice for Evaluating Drug Responses in Patients with Head and Neck Cancers, the Window of Opportunity Study
Status: Active
Location: 2 locations
Nivolumab plus Axitinib for the Treatment of Stage III or IV Melanoma
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Axitinib and Ipilimumab for the Treatment of Advanced Melanoma
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Adaptive Pembrolizumab and Axitinib for the Treatment of Advanced Clear Cell Renal Cell Carcinoma
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
L-selenomethionine with Axitinib and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Clear Cell Kidney Cancer
Status: Active
Location: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas